Company: AGIO
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001193125-25-096719
Chunk: 48

Company: AGIOS PHARMACEUTICALS, INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 48
---
-Based Payments, of the Notes to our Consolidated Financial Statements in our Annual Report on Form 10-K filed with the SEC on February 13, 2025. |

34

| (4) | The aggregate number of shares of common stock underlying RSUs outstanding as of December 31, 2024 were: Dr. Ballal: 4,422, Mr. Capello: 6,073, Ms. Foster: 2,120, Dr. Fouse: 18,053, Dr. Ho: 2,120, Ms. Owen: 6,073, Dr. Scadden: 2,120, Dr. Schenkein: 2,120 and Ms. Smith: 4,422. |

| (5) | Dr. Schenkein resigned from our board of directors effective February 28, 2025. |

Mr. Goff, who serves as our chief executive officer and a member of our board of directors, did not receive any additional compensation for his service as a director during 2024. The compensation that we paid to Mr. Goff in his role as our chief executive officer is disclosed under “Executive Compensation–Summary Compensation Table.” Limitation of Liability and Indemnification Our certificate of incorporation limits the personal liability of directors for breach of fiduciary duty to the maximum extent permitted by the Delaware General Corporation Law and provides that no director will have personal liability to us or to our stockholders for monetary damages for breach of fiduciary duty or other duty as a director. However, these provisions do not eliminate or limit the liability of any of our directors:

| • |     | for any breach of the director’s duty of loyalty to us or our stockholders; |

| • |     | for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law; |

| • |     | for voting or assenting to unlawful payments of dividends, stock repurchases or other distributions; or |

| • |     | for any transaction from which the director derived an improper personal benefit. |

**Any amendment to or repeal of these provisions will not eliminate or reduce the effect of these provisions in respect of any act, omission or claim that occurred or arose prior to such amendment or repeal. If the Delaware General Corporation Law is amended to provide for further limitations on the personal liability of directors of corporations, then the personal liability of our directors will be further limited to the greatest extent permitted by the Delaware General Corporation Law